Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

May 2018; 5 (3) Clinical/Scientific NotesOpen Access

Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms in NMOSD

Yuri Mizuno, Koji Shinoda, Mitsuru Watanabe, Takuya Matsushita, Ryo Yamasaki, Jun-ichi Kira
First published February 21, 2018, DOI: https://doi.org/10.1212/NXI.0000000000000447
Yuri Mizuno
From the Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koji Shinoda
From the Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuru Watanabe
From the Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuya Matsushita
From the Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryo Yamasaki
From the Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun-ichi Kira
From the Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms in NMOSD
Yuri Mizuno, Koji Shinoda, Mitsuru Watanabe, Takuya Matsushita, Ryo Yamasaki, Jun-ichi Kira
Neurol Neuroimmunol Neuroinflamm May 2018, 5 (3) e447; DOI: 10.1212/NXI.0000000000000447

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1030

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune demyelinating disorder of the CNS that frequently affects brainstem functions.1 Trigeminal neuralgia occurs in 2.5% of patients with NMOSD1; however, the occurrence of trigeminal autonomic cephalalgia (TAC) is rarely reported.2,3 Here, we describe a case of NMOSD with anti–aquaporin-4 (AQP4) antibodies who had a relapse with brainstem and cervical spinal cord lesions manifesting as short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), a rare form of TAC.

Case report

A 55-year-old woman developed intractable hiccups and vomiting that lasted for 1 month. Three weeks after the onset, she noticed dysesthesia in her upper extremities and was referred to our hospital. Neurologic examination revealed red desaturation in both eyes, despite normal visual acuity and pupillary reflexes, positive Lhermitte sign, and bilateral dysesthesia at the C8-Th1 dermatomes. Serum anti-AQP4 antibodies were positive by a cell-based assay. MRI revealed a longitudinally extensive spinal cord lesion encompassing 3 vertebral segments from C7 to Th2 spine levels. She was diagnosed as having NMOSD and treated with intravenous methylprednisolone (IV-MP, 1,000 mg/d for 3 days). Plasmapheresis was also performed because of the suboptimal effects of IV-MP on dysesthesia. To prevent relapses, oral prednisolone therapy was initiated at 30 mg/d, which was gradually tapered and maintained at 11 mg/d until the second attack.

At 57 years of age, she developed intermittent, 1–3-minute-lasting severe, tingling, and stabbing pain around the left eye, constantly accompanied by ipsilateral rhinorrhea and lacrimation 5–20 times a day. A facial photograph during a headache attack is presented in figure, A. This pain was inducible by stimulation of the left side of her face without any cessation after each attack, and it was refractory to oral loxoprofen, ibuprofen, indomethacin, and carbamazepine. Neurologic examination revealed only mild hypoalgesia on the left side of her face during the remission of headache. Surprisingly, brain MRI revealed new T2-hyperintense lesions in the left dorsolateral medulla oblongata and left dorsal cervical spinal cord at the C1/2 spine level (figure, B and C). Gadolinium-enhancement was observed in the cervical cord lesion (figure, D). Three-dimensional double inversion recovery images clearly showed hyperintense lesions (figure, E–H). We diagnosed her as having SUNA with a relapse of NMOSD. IV-MP (1,000 mg/d for 3 days) and oral lamotrigine (25 mg/d) were initiated 10 days after the onset. Headache attacks began to decrease after the initiation of treatment. Subsequently, the dose of lamotrigine was increased to 75 mg/d, and a second course of IV-MP was performed based on the insufficient treatment response. Headache attacks disappeared completely 21 days after the onset. Oral tacrolimus (3 mg/d) was added to prevent further relapses. Thereafter, she has not suffered any recurrence for 10 months.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Facial photograph during headache attack and brain and upper cervical cord MRI

(A) Facial photograph during headache attack showing rhinorrhea and lacrimation on the left side (arrows). Written informed consent was obtained to show part of the face without masking. (B) Sagittal fluid-attenuated inversion recovery (FLAIR), (C) an axial FLAIR image at the level of the lower medulla oblongata, and (D) gadolinium-enhanced T1-weighted images of the brain. Three-dimensional double inversion recovery images in sagittal (E), coronal (F), and axial planes (G, medulla oblongata; H, lower medulla oblongata). Arrowheads indicate lesions.

Discussion

We described a case of NMOSD with anti-AQP4 antibodies, who had a relapse manifesting as SUNA. SUNA and short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) are rare forms of TAC.4 SUNA is defined as having only one or neither of conjunctival injection or lacrimation, whereas SUNCT is defined as having both symptoms. The occurrence of SUNA/SUNCT is rare and was reported only twice previously.2,3 A longitudinal brainstem lesion caused SUNCT in a patient with Devic syndrome without reference to anti-AQP4 antibodies; however, axial distribution of the medullary lesion was not shown.2 The occurrence of unilateral TAC, probably SUNCT, was also described in a patient with NMOSD with anti-AQP4 antibodies who developed a lesion at the center of the medulla oblongata.3 Our case clearly had a left dorsolateral medulla oblongata lesion, which included the left spinal nucleus of the trigeminal nerve that corresponded with the left side SUNA. Furthermore, the lesion responsible for SUNA in our patient confirms a report of infarction in the right dorsal medulla oblongata, which caused SUNCT.5

SUNA/SUNCT is highly refractory to medication. Antiepileptic drugs or corticosteroids and surgical treatment are used to suppress SUNA/SUNCT. Of these, a good-to-excellent response to lamotrigine was observed in 11/19 cases (58%) of SUNA/SUNCT.6 Likewise, another study reported that lamotrigine was effective in 4/5 SUNCT cases (80%).7 Indeed, in our patient, where SUNA was refractory to oral loxoprofen, diclofenac, indomethacin, and carbamazepine, the use of lamotrigine and IV-MP successfully alleviated SUNA attacks. The association of TAC including SUNA with NMOSD was suggested by the treatment response and the clearly visualized ipsilateral dorsal medulla lesion, compatible as a causative lesion of SUNA/SUNCT. We propose that neurologists should be aware that SUNA/SUNCT could be the sole brainstem manifestation of NMOSD and a combination of immunotherapies and lamotrigine should be considered for such cases.

Author contributions

Dr. Mizuno treated the patient and drafted the manuscript. Dr. Shinoda treated the patient and drafted/revised the manuscript. Dr. Watanabe treated the patient. Dr. Matsushita and Dr. Yamasaki drafted/revised the manuscript. Dr. Kira supervised the treatment and manuscript writing.

Study funding

This study was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases (H26-Nanchitou (Nan)-Ippan-043) from the Ministry of Health, Labour and Welfare, Japan, a Grant-in-Aid for Scientific Research A (MEXT KAKENHI Grant No. 16H02657) and C (15K09341), and a Grant-in-Aid for Young Scientists B (17K16124, 17K16125) from the Japan Society for the Promotion of Science, Japan.

Disclosure

Y. Mizuno reports no disclosures. K. Shinoda received speaker honoraria from Takeda Pharmaceutical and Biogen and received research support from the Japanese Multiple Sclerosis Society and Japan Intractable Disease Research Foundation. M. Watanabe received research support from GSK Japan and the Japan Society for the Promotion of Science. T. Matsushita received speaker honoraria from Bayer-Schering, Mitsubishi Tanabe, Biogen, and Takeda Pharmaceuticals and received research support from the Japan Society for the Promotion of Science. R. Yamasaki reports no disclosures. J.-i. Kira received travel funding from Bayer and Biogen; served on the editorial board of Multiple Sclerosis, BMC Medicine, Journal of the Neurological Sciences, Multiple Sclerosis and Related Disorders, PLoS One, Acta Neuropathologica Communications, and Clinical and Experimental Neuroimmunology; and received research support from the Ministry of Health, Labour, and Welfare, Japan, and Japan Agency for Medical Research and Development; Grant-in-Aid. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NN.

Footnotes

  • Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NN.

  • The Article Processing Charge was funded by Mount Sinai.

  • Received October 21, 2017.
  • Accepted in final form January 5, 2018.
  • Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Kremer L,
    2. Mealy M,
    3. Jacob A, et al
    . Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Mult Scler 2014;20:843–847.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Kursun O,
    2. Arsava EM,
    3. Oguz KK,
    4. Tan E,
    5. Kansu T
    . SUNCT associated with Devic's syndrome. Cephalalgia 2006;26:221–224.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Mathew T,
    2. Nadimpally US,
    3. Sarma GR,
    4. Nadig R
    . Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: “A rare combination of two uncommon disorders”. Mult Scler Relat Disord 2016;6:73–74.
    OpenUrl
  4. 4.↵
    Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Lambru G,
    2. Trimboli M,
    3. Tan SV,
    4. Al-Kaisy A
    . Medullary infarction causing coexistent SUNCT and trigeminal neuralgia. Cephalalgia 2017;37:486–490.
    OpenUrl
  6. 6.↵
    1. Williams MH,
    2. Broadley SA
    . SUNCT and SUNA: clinical features and medical treatment. J Clin Neurosci 2008;15:526–534.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. D'Andrea G,
    2. Granella F,
    3. Ghiotto N,
    4. Nappi G
    . Lamotrigine in the treatment of SUNCT syndrome. Neurology 2001;57:1723–1725.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Case report
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

Dr. Ann Yeh and Dr. Daniela Castillo Villagrán

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Demyelinating disease (CNS)
  • All Headache
  • MRI

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Brief Communications
    Chronic paroxysmal hemicrania–tic syndrome
    E. Zukerman, M.F. P. Peres, A.O. Kaup et al.
    Neurology, April 11, 2000
  • Article
    Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes
    Christian Ziegeler, Arne May et al.
    Neurology, August 21, 2019
  • Editorial
    About the understanding of classifications using SUNCT and SUNA as an example
    Arne May et al.
    Neurology, August 19, 2019
  • Article
    A prospective comparative study and analysis of predictors of SUNA and SUNCT
    Giorgio Lambru, Khadija Rantell, Andrew Levy et al.
    Neurology, August 19, 2019
Neurology - Neuroimmunology Neuroinflammation: 10 (6)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise